IL6 and neoplasm: High levels of serum IL-1β and IL-6 levels correlated with delayed tumor progression in animals bearing 4T1 tumors treated with mcr84 and GU81, whereas low levels of these cytokines corresponded to tumor progression (Fig. 8A–C).